Upstream Bio (UPB) Liabilities and Shareholders Equity (2023 - 2025)
Historic Liabilities and Shareholders Equity for Upstream Bio (UPB) over the last 3 years, with Q3 2025 value amounting to $391.2 million.
- Upstream Bio's Liabilities and Shareholders Equity rose 6811.13% to $391.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.7 billion, marking a year-over-year increase of 40003.26%. This contributed to the annual value of $481.7 million for FY2024, which is 31103.01% up from last year.
- Per Upstream Bio's latest filing, its Liabilities and Shareholders Equity stood at $391.2 million for Q3 2025, which was up 6811.13% from $420.5 million recorded in Q2 2025.
- In the past 5 years, Upstream Bio's Liabilities and Shareholders Equity ranged from a high of $481.7 million in Q4 2024 and a low of $117.2 million during Q4 2023
- Moreover, its 3-year median value for Liabilities and Shareholders Equity was $405.9 million (2025), whereas its average is $349.9 million.
- Its Liabilities and Shareholders Equity has fluctuated over the past 5 years, first soared by 31103.01% in 2024, then surged by 6811.13% in 2025.
- Quarter analysis of 3 years shows Upstream Bio's Liabilities and Shareholders Equity stood at $117.2 million in 2023, then surged by 311.03% to $481.7 million in 2024, then fell by 18.79% to $391.2 million in 2025.
- Its Liabilities and Shareholders Equity stands at $391.2 million for Q3 2025, versus $420.5 million for Q2 2025 and $456.2 million for Q1 2025.